From: Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients
With pre-transplant PVT (n = 62) | Without pre-transplant PVT (n = 318) | Significance | |
---|---|---|---|
Child/adult recipient | 2/60 | 48/270 | p = 0.011 |
Male/female recipient | 44/18 | 210/108 | p = 0.451 |
Associated tumor (Yes/No) | 15/32 | 63/133 | p = 0.951 |
Diabetes mellitus and/or high lipid (Yes/No) | 24/25 | 68/135 | p = 0.043 |
Inflammatory disease (Yes/No) | 0/39 | 0/183 | p = N |
Smoking (Yes/No) | 20/26 | 111/92 | p = 0.169 |
Inmobility (Yes/No) | 3/36 | 9/166 | p = 0.531 |
Surgery Intervention (Yes/No) | 24/23 | 104/103 | p = 0.919 |
Obesity (Yes/No) | 5/37 | 4/178 | p = 0.004 |
Nephrotic syndrome (Yes/No) | 0/39 | 14/163 | p = 0.069 |
Myeloproliferative syndrome (Yes/No) | 2/39 | 0/185 | p = 0.003 |
Trauma (Yes/No) | 3/37 | 10/171 | p = 0.631 |
Cause of liver transplantation | p = 0.135 | ||
BHV | 2 | 16 | |
CHV | 12 | 61 | |
Ethanol | 14 | 48 | |
Autoimmune | 3 | 5 | |
Toxicity | 1 | 7 | |
Tumor | 7 | 22 | |
Cryptogenetic | 1 | 14 | |
Vascular | 2 | 0 | |
Infrequent (deficit alpha1 antitrypsin) | 3 | 23 | |
Biliary atresia | 2 | 22 | |
BHV and CHV | 10 | 42 | |
BHV and CHV and Tumor | 5 | 58 |